جستجوی استاد راهنمای دانشگاهی

Anne Berit C. Samuelsen serves as Associate Professor at the Department of Pharmacy, University of Oslo, where she also holds the position of Head of Education. Her academic foundation includes a Cand.pharm. degree and Dr.scient. doctorate, establishing her expertise in pharmaceutical sciences. Her research centers on polysaccharides from natural sources—particularly higher plants, cereals, and fungi (Basidiomycota)—with specialized focus on β-glucans. Key interests include carbohydrate chemistry, pharmacognosy, and the development of biopolymer-based pharmaceutical applications. Her work bridges fundamental structural characterization with practical drug delivery solutions, notably through liposome coating technologies and immunomodulatory compound development. Recent publications reveal a strong trajectory in fungal polysaccharide research, particularly with Pleurotus eryngii and Albatrellus ovinus species. Her team employs advanced techniques like diffusion-ordered NMR spectroscopy to analyze polysaccharide structures while investigating biological activities related to immune receptor binding (Dectin-1, Toll-like receptors) and therapeutic applications. This work demonstrates consistent output in high-impact journals including Carbohydrate Polymers and ACS Applied Bio Materials . She actively contributes to academic instruction through courses such as FARM1150 (Pharmaceutically Oriented Biochemistry), FARM3100 (Pharmacognosy), and FARM5200 (Use of Biopolymers in Pharmaceuticals). Her leadership extends to the Bioactive Natural Substances and Health Effects (BioNatH) research group and the Glyconor Consortium, where she investigates natural product applications for health improvement.

• Polysaccharide Chemistry
• Pharmacognosy
• Carbohydrate Polymers
• +۴ مورد دیگر

Per Sigvald Bakke is a Professor at the University of Bergen's Faculty of Medicine, Department of Clinical Science, with extensive expertise in respiratory medicine. His research primarily focuses on Chronic Obstructive Pulmonary Disease (COPD), asthma, and related pulmonary conditions, with significant contributions to understanding disease mechanisms, clinical phenotyping, and epidemiology. Dr. Bakke's research interests span COPD phenotyping, asthma heterogeneity, genomics of respiratory diseases, pulmonary function testing, and clinical epidemiology. His work frequently involves large-scale cohort studies and international collaborations, particularly through the U-BIOPRED consortium. His research has significantly advanced understanding of COPD progression, exacerbation risk factors, and the relationship between respiratory diseases and systemic conditions like metabolic syndrome. His publication record demonstrates consistent contributions to respiratory medicine, with recent work focusing on multi-omics approaches to disease phenotyping, genetic determinants of lung function, and clinical management of COPD. His research often bridges basic science with clinical application, addressing critical questions in respiratory disease management and patient outcomes. Dr. Bakke has been instrumental in numerous international collaborative studies including the ECLIPSE cohort, U-BIOPRED, and various genome-wide association studies examining COPD and asthma. His work has contributed to clinical guidelines and improved understanding of respiratory disease mechanisms across diverse populations.

• Chronic Obstructive Pulmonary Disease (COPD)
• Respiratory Medicine
• Asthma
• +۴ مورد دیگر

Ulrik Wisløff is a Professor and Head of the Cardiac Exercise Research Group (CERG) at the Norwegian University of Science and Technology (NTNU), Department of Circulation and Medical Imaging. He also holds an Honorary Professorship at the University of Queensland, Australia, and serves as Head of Physical Performance at Rosenborg FC. His research focuses on exercise physiology, translating experimental findings into clinical applications, and developing health technologies like the PAI (Personal Activity Intelligence) metric. Wisløff leads CERG, a 55-member group renowned for groundbreaking studies on exercise in cardiovascular health, aging, and disease prevention. He has authored over 340 peer-reviewed papers, with 127,000+ citations, and been recognized as one of the world's top-cited exercise scientists. Key achievements include the Fitness Calculator (used by 80.5 million people) and PAI, a free app with 70 million users worldwide. Current projects include NorEx (9,700 patients with myocardial infarction) and ExPlas (Alzheimer’s cognitive function trials). Wisløff has mentored 22 postdocs and 38 PhD students, advancing the next generation of researchers. His leadership extends to innovative ventures like the 'My Medical Digital Twin' project, spun into Mia Health Ltd. Scientific contributions span exercise physiology, cardiovascular risk prediction, and high-intensity training efficacy. Awards include Norway’s highest honor in heart research (2020). Research spans molecules-to-society translational medicine, emphasizing global health impact through physical activity advocacy.

• Exercise Physiology
• Cardiovascular Health
• Exercise as Medicine
• +۳ مورد دیگر

Jan Helgerud is a Professor in the Department of Circulation and Medical Imaging at the Norwegian University of Science and Technology (NTNU), Faculty of Medicine and Health Sciences. His research focuses on exercise physiology, endurance training, and cardiovascular health, with particular emphasis on aerobic capacity, muscle strength, and their clinical applications in chronic diseases and rehabilitation. Research Interests: Exercise physiology and its impact on health and disease High-intensity interval training (HIIT) adaptations in athletes and clinical populations Cardiovascular and metabolic responses to exercise Strength training in patients with rheumatic diseases, Parkinson's disease, and spinal cord injuries Physiological determinants of endurance performance in sports like cycling and cross-country skiing Recent Article Trends: Recent work emphasizes the efficacy of high-intensity training protocols for improving aerobic capacity (VO2max) and functional outcomes in diverse populations, including elite athletes and patients with long-term conditions like long-COVID or rheumatic diseases. Studies also explore mechanisms of muscle adaptation, heat tolerance in occupational settings, and digital health tools for exercise assessment. Advising & Grants: Collaborations with colleagues on randomized controlled trials for strength and endurance interventions Focus on translational research linking physiological insights to clinical outcomes Labs/Teams: Active in NTNU's Department of Circulation and Medical Imaging, contributing to interdisciplinary projects in sports science and rehabilitation medicine.

• Exercise Physiology
• Endurance Training
• Cardiovascular Health
• +۳ مورد دیگر

Bjørn Olav Åsvold, MD, PhD, is a Professor of Medicine (Epidemiology) and Center leader at the HUNT Centre for Molecular and Clinical Epidemiology (HUNT MCE), Department of Public Health and Nursing, Norwegian University of Science and Technology (NTNU). He also serves as a Consultant at the Department of Endocrinology, St. Olavs Hospital, Trondheim University Hospital. His research spans epidemiology, genetics, and clinical medicine. MD, Norwegian University of Science and Technology, 2001 PhD, Norwegian University of Science and Technology, 2008 Specialist in internal medicine, 2014 Specialist in endocrinology, 2015 Åsvold's research focuses on thyroid dysfunction and diabetes , investigating their interplay with cardiometabolic diseases and pregnancy complications . He utilizes Mendelian randomization studies to explore causal relationships between genetic factors and health outcomes, including sleep traits , autoimmune thyroid disease , and kidney function . His work also addresses global health issues like obesity in Nepal and diabetic complications in Norway. Recent publications highlight his contributions to understanding hip fracture risk prediction , cardiovascular implications of sleep patterns , and genetic determinants of trace elements . Åsvold's collaborations span multiple international institutions, including the HUNT Study and HUNT MCE in Norway.

• Thyroid dysfunction
• Diabetes
• Pregnancy complications and cardiovascular risk
• +۱ مورد دیگر

Eva Gerdts is a Professor at the Clinical Institute 2, University of Bergen, and is affiliated with Haukeland University Hospital. She is a Member of the Norwegian Academy of Sciences and leads the Bergen Hypertension and Cardiac Dynamics Group. Her work is central to the Center for Research on Heart Disease in Women, established in 2020 with support from the Heart Foundation, Bergen Women's Health Association, and the Grieg Foundation. University: University of Bergen Affiliation: Clinical Institute 2 Research Group: Hypertension and Cardiac Dynamics Center: Center for Research on Heart Disease in Women Email: eva.gerdts@uib.no Her research focuses on heart disease in women , particularly as influenced by hypertension, aortic valve stenosis, obesity, and autoimmune diseases. She investigates sex-specific differences in cardiac strain, arterial stiffness, and myocardial remodeling. Her work emphasizes how male-based data cannot be extrapolated to women, advocating for gender-specific cardiovascular guidelines. Her recent publications span population studies like the Tromsø and Hordaland Health Surveys, clinical trials, and international collaborations. Key trends include sex differences in hypertension outcomes , cardiac effects of bariatric surgery , cryptogenic stroke in young adults , and inflammatory markers in autoimmune diseases . Her research integrates echocardiography, longitudinal data, and public health implications. Scientific recognition includes: Member of the Norwegian Academy of Sciences National Heart Association's Heart Research Prize 2022 She supervises multiple PhD and Master’s students, including Ester Kringeland, Sahrai Saeed, and Arleen Aune. She leads the PhD course NORHEART901 in Cardiovascular Imaging and teaches in medical education on hypertension, cardiac ultrasound, and women's heart health. Her research is supported by large-scale population studies and clinical collaborations, particularly through the NOR-SYS and SECRETO projects. She also organizes professional education on valvular disease and dyspnea. She leads or collaborates with several research teams: Bergen Hypertension and Cardiac Dynamics Group Center for Research on Heart Disease in Women NOR-SYS (Norwegian Stroke in the Young Study) SECRETO (Searching for Explanations for Cryptogenic Stroke in the Young) FATCOR Study (Fitness, Adiposity, and Cardiovascular Risk)

• Cardiovascular Medicine
• Hypertension
• Heart Disease in Women
• +۷ مورد دیگر

Joao Carlos Amaro Ferreira is a Professor at the Faculty of Logistics, Molde University College (HiMolde), Norway. He holds PhDs in Computer Engineering and Industrial Engineering from the Technical University of Lisbon and the University of Minho, respectively. His research focuses on Artificial Intelligence (AI) applications in healthcare, energy, transportation, IoT, blockchain, and smart cities. He has led over 40 projects, including 6 as Principal Investigator, and contributed to international conferences like OAIR and INTSYS. He served as IEEE CIS President (2016-2018) and is an IEEE Senior Member since 2015. His academic contributions span AI-driven solutions for public sector informatics, healthcare data quality, and cybersecurity. He actively participates in European projects such as e-Hospital4Future and explores blockchain applications in supply chains and medical records. Ferreira leads the ABC-AI research group, emphasizing ethical and applied AI. His work bridges academia and industry through projects like gamification systems for eco-driving and AI in fisheries traceability. Recent publications highlight AI's role in cardiovascular disease detection, emergency department optimization, and blockchain-enhanced healthcare interoperability. He collaborates internationally, co-editing journals like Applied Sciences , and has authored patents in edge computing for maritime monitoring.

• Artificial Intelligence
• AI in Health and Medicine
• AI in Energy and Transportation
• +۶ مورد دیگر

Neil Martin Davies is a Researcher at the Department of Public Health and Nursing , Norwegian University of Science and Technology (NTNU) . His work bridges epidemiology, genetics, and public health, with a focus on causal inference, Mendelian randomization, and socioeconomic health disparities. His research explores the intersection of genetic epidemiology , developmental psychology , and clinical outcomes . Key themes include the impacts of antiseizure medications in pregnancy , cardiometabolic risks in psychiatric populations , and health policy implications of Mendelian randomization . Recent publications highlight methodological advancements in directed acyclic graphs (DAGs) , instrumental variable analysis , and family-based sampling . His work frequently addresses parental education effects , sleep patterns , and genetic correlations in large cohorts like UK Biobank. Neil Martin Davies contributes to scientific reporting standards , co-authoring the STROBE-MR guidelines for Mendelian randomization studies. His collaborations span neurology , mental health , and health economics , emphasizing causal relationships over correlational findings.

• Epidemiology
• Genetic Epidemiology
• Public Health
• +۹ مورد دیگر

Dr. Espen Molden is an Adjunct Professor at the Department of Pharmacy, University of Oslo, holding a 20% position while serving as Research Manager at the Center for Psychopharmacology, Diakonhjemmet Hospital. He earned his Cand.pharm. degree from the University of Oslo in 1997 and completed his Dr.scient. there in 2003. His primary research focuses on individual variability in drug efficacy and side effects, with particular emphasis on implementing pharmacogenetic knowledge in clinical practice. His research interests span multiple areas of pharmacology, including: Pharmacokinetics and therapeutic drug monitoring Pharmacogenetics (particularly CYP2D6 and CYP2C19) Drug interactions and cytochrome P450 metabolism Clinical applications in psychopharmacology Analysis of his 15 most recent publications (2024-2025) reveals a strong focus on pharmacogenetics applications in clinical settings, particularly in psychopharmacology. His work heavily features therapeutic drug monitoring studies, CYP enzyme polymorphisms, and their clinical implications for antipsychotic and antidepressant treatments. A significant portion of his recent work examines clozapine metabolism, CYP2D6-related pharmacogenetics, and real-world data applications in personalized medicine. His scientific achievements include: Pharmacist of the Year award from the Norwegian Pharmaceutical Association (2006) Extensive publication record in high-impact journals including Nature Genetics, JAMA, and Clinical Pharmacology & Therapeutics Leadership in large collaborative research projects across multiple institutions Dr. Molden actively collaborates with numerous researchers including Professor Torgeir Bruun Wyller at Oslo University Hospital, Professor Anette Hylen Ranhoff at Diakonhjemmet Hospital, and international colleagues from institutions like Karolinska Institutet. His work bridges basic pharmacogenetic research with clinical implementation, particularly in psychiatric medication management.

• Pharmacology
• Pharmacokinetics
• Pharmacogenetics
• +۴ مورد دیگر

Jan Olav Høgetveit is an Associate Professor in the Department of Physics at the University of Oslo (UiO), within the Faculty of Mathematics and Natural Sciences. He also serves as Head of Research & Development in the Department of Biomedical and Clinical Engineering at Rikshospitalet, Norway’s national hospital. His work bridges physics and clinical practice, focusing on medical instrumentation. Education: Bachelor of Electronic Engineering (Technical Cybernetics), Oslo University College, 1993 Master of Electronics, University of Oslo (Department of Physics), 1997 Ph.D. in Physics (Technology Applications for Medical Devices), University of Oslo, 2008 Research Interests: Høgetveit specializes in biomedical instrumentation and clinical engineering, particularly in surgical technology and wireless communication impacts on medical devices. His work addresses challenges like real-time physiological monitoring during heart-lung machine use, non-invasive blood glucose detection, and bioimpedance-based viability assessment of organs. He emphasizes interdisciplinary collaboration between engineering and medicine to enhance patient safety and surgical outcomes. Scientific Contributions: His research trends span bioimpedance applications in ischemia/reperfusion injury, machine learning for surgical decision support, and electrosurgery safety. He has explored ventilator optimization during pandemics and implant-related thermal risks. Contributions highlight both hardware development (e.g., optically isolated current sources) and software innovations (e.g., neural networks for viability prediction). Awards: No scientific awards explicitly mentioned in the text. Advising & Grants: Høgetveit received a 1998–2001 research council scholarship. As Head of R&D since 2001, he oversees translational projects. No formal advisees/students listed, though he collaborates extensively with teams on device development and clinical trials. Labs & Teams: Affiliated with UiO’s Department of Physics and Rikshospitalet’s Biomedical and Clinical Engineering department. Active in the Electronics research group at UiO. Engages with multidisciplinary teams addressing surgical instrumentation and physiological monitoring challenges.

• Biomedical Instrumentation
• Medical Technology
• Clinical Engineering
• +۳ مورد دیگر

Anton Baysa is a Senior Lecturer at the University of Oslo's Department of Pathology within the Faculty of Medicine. His research focuses on cardiovascular pathophysiology, particularly mechanisms of inflammation, mitochondrial dysfunction, and cellular repair following myocardial infarction and ischemia-reperfusion injury. He has published extensively on topics including Toll-like receptor signaling, mitochondrial DNA-induced inflammation, and the role of adaptor proteins in cardiac healing. His work integrates molecular biology, immunology, and clinical cardiology to understand and mitigate cardiac damage. Collaborative projects include studies on extracellular vesicles in surgery-related complications and growth factor pathways in myocardial repair. Key Research Themes: Cardiac inflammation mechanisms, mitochondrial damage responses, post-infarction healing, oxidative stress mitigation Recent Projects: Investigating p66ShcA protein signaling, nucleolin inhibition effects, and BMP-mediated cardiac remodeling

• Cardiology
• Molecular Biology
• Cardiovascular Pathology
• +۵ مورد دیگر

Hilde Moseby Berge serves as an Associate Professor in the Department of Sports Medicine at the Norwegian School of Sport Sciences. She is actively engaged in research and clinical work focused on sports medicine, particularly in the areas of sports cardiology and Para athlete health. Her contact information indicates ongoing institutional affiliation with direct lines for professional communication. Dr. Berge's research interests center on cardiovascular health in athletes, with particular emphasis on sudden cardiac arrest prevention, ECG interpretation in sports settings, and health monitoring systems for elite athletes. Her work spans both Olympic and Paralympic populations, with significant contributions to understanding injury and illness patterns among these athletes. She has developed expertise in periodic health evaluations and has led initiatives to improve cardiac emergency response in sports settings, particularly through projects like ParaFRISK and YoungParaFRISK. Analysis of her publication record reveals consistent focus on cardiovascular incidents in sports, particularly examining the limitations of cardiac screening programs and the prevalence of cardiac events even among athletes with previously negative screening results. Her more recent work has expanded to include comprehensive health monitoring systems for Paralympic athletes and community-based interventions to improve survival from cardiac events in sports settings. Her research bridges clinical practice with epidemiological investigation, contributing significantly to evidence-based approaches in sports medicine. Dr. Berge maintains active collaborations with key researchers in sports medicine including Kathrin Steffen, Benjamin Clarsen, and Roald Bahr. Her work has contributed to national health monitoring programs for Norwegian Olympic and Paralympic athletes, with longitudinal data collection spanning multiple Games cycles. She appears to be involved in practical implementation of health services during major sporting events, as indicated by her publications related to preparation for the Tokyo and Paris Games.

• Sports Cardiology
• Cardiovascular Incidents in Athletes
• Paralympic Athlete Health
• +۴ مورد دیگر

Tor Iversen is a Professor of Health Economics at the University of Oslo, affiliated with the Department of Health Management and Health Economics within the Institute of Health and Society. He holds a Ph.D. in Economics (1993) and a cand. oecon. (1978) from the University of Oslo. His research focuses on market conditions in healthcare, economic incentives for healthcare providers, and policy evaluations such as free choice reforms and primary care team models. Education: Doctorate in Economics (1993), University of Oslo; cand. oecon. (1978), University of Oslo. Research Interests: Non-price rationing mechanisms in healthcare, economic incentives in long-term care, digital surveillance for chronic disease management, and cross-country comparisons of treatment outcomes and costs. Current projects include evaluations of Norway’s primary healthcare teams pilot program, telemedicine interventions for chronic conditions, and cost-effectiveness analyses of healthcare policies. Professional Activities: Iversen has held editorial roles at the International Journal of Health Care Finance and Economics and the Nordic Journal of Health Economics . He collaborates with institutions globally, including Karolinska Institutet, Harvard University, and the University of Melbourne. His research emphasizes healthcare access, provider behavior, and policy impacts. Grants/Advising: Led evaluations of healthcare reforms and pilot programs, including the Norwegian Primary Healthcare Teams project. His work often involves interdisciplinary teams and practical policy applications. Labs/Teams: Part of the Health Economics Research Programme (HERO) and contributed to initiatives like NORCHER (Norwegian Centre for Health Services Research) and the OMIT cohort study on diabetes outcomes.

• Health Economics
• Health Policy
• Healthcare Management
• +۵ مورد دیگر

Hilde Moseby Berge is an Associate Professor in the Department of General Practice at the University of Oslo. Her research focuses on cardiovascular health in athletes, injury and illness prevention in elite sports, and the psychological and social impacts of cardiac arrest survival among young exercisers. She has collaborated extensively with institutions like the Norwegian Olympic and Paralympic committees, contributing to longitudinal health monitoring programs for athletes. Her work includes evaluating automated external defibrillator (AED) availability in sports clubs and analyzing post-surgical outcomes for musculoskeletal injuries. Berge is also affiliated with the Clinical General Practice Research (Allmix) and General Practice Health Services Research (ALHF) groups, emphasizing her commitment to practical healthcare solutions. Key research themes include: 1) Cardiac events in sports contexts, 2) Health disparities affecting Paralympic athletes, and 3) Long-term health surveillance for Olympic/Paralympic participants. Her studies often use systematic reviews and multi-year cohort analyses, with findings published in journals like British Journal of Sports Medicine and Resuscitation . Berge’s contributions to healthcare systems include designing prevention protocols for sudden cardiac arrest and investigating bone density issues in elite Para athletes. She has co-authored over 15 peer-reviewed articles since 2014, addressing topics such as ECG interpretation in athletes, post-cardiac arrest quality of life, and the epidemiology of sports-related injuries. Her work bridges clinical research and real-world healthcare applications, particularly in sports medicine and emergency preparedness.

• Sports Medicine
• Cardiovascular Health
• Health Services Research
• +۷ مورد دیگر

Eva Langvik is a Professor in the Department of Psychology at the Norwegian University of Science and Technology (NTNU). Her work focuses on depression, health psychology, personality assessment, and occupational psychology. She has extensively published on topics such as moral stress in law enforcement, workplace well-being, and psychological factors in cardiovascular health. Her research interests include the intersection of personality traits and health outcomes, particularly in high-stress professions like policing. Studies often address stress management, organizational support systems, and the psychological impact of working with child abuse cases. Recent articles highlight her analysis of police employees’ experiences with workload and organizational resources, as well as investigations into public perception of offenders and patient experiences in clinical settings. She collaborates with institutions like the NTNU Department of Psychology and the Trøndelag Police District.

• Depression
• Health Psychology
• Heart diseases
• +۶ مورد دیگر